Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Infectious Disease In-vitro Diagnostics Market, By Product
7.1. Infectious Disease In-vitro Diagnostics Market, by Product Type, 2021-2030
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Reagents
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Infectious Disease In-vitro Diagnostics Market, By Technology
8.1. Infectious Disease In-vitro Diagnostics Market, By Technology, 2021-2030
8.1.1. Immunoassay
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Molecular Diagnostics
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Microbiology
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Infectious Disease In-vitro Diagnostics Market, By Application
9.1. Infectious Disease In-vitro Diagnostics Market, By Application, 2021-2030
9.1.1. MRSA
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Streptococcus
9.2. Market Revenue and Forecast (2016-2030)
9.2.1. Clostridium Difficile
9.3. Market Revenue and Forecast (2016-2030)
9.3.1. VRE
9.4. Market Revenue and Forecast (2016-2030)
9.4.1. CRE
9.5. Market Revenue and Forecast (2016-2030)
9.5.1. Respiratory Virus
9.6. Market Revenue and Forecast (2016-2030)
9.6.1. Candida
9.7. Market Revenue and Forecast (2016-2030)
9.7.1. TB and Drug-resistant TB
9.8. Market Revenue and Forecast (2016-2030)
9.8.1. Gastro-intestinal Panel Testing
9.9. Market Revenue and Forecast (2016-2030)
9.9.1. Chlamydia
9.10. Market Revenue and Forecast (2016-2030)
9.10.1. Gonorrhea
9.11. Market Revenue and Forecast (2016-2030)
9.11.1. HPV
9.12. Market Revenue and Forecast (2016-2030)
9.12.1. HIV
9.13. Market Revenue and Forecast (2016-2030)
9.13.1. Hepatitis C
9.14. Market Revenue and Forecast (2016-2030)
9.14.1. Hepatitis B
9.15. Market Revenue and Forecast (2016-2030) )
9.15.1. COVID-19
9.16. Market Revenue and Forecast (2016-2030) )
9.16.1. Others
9.16.1.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Infectious Disease In-vitro Diagnostics Market, By End-Use
10.1. Infectious Disease In-vitro Diagnostics Market, By End-Use, 2021-2030
10.1.1. Point of care
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Central Laboratories
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Infectious Disease In-vitro Diagnostics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, By Technology (2016-2030)
11.1.3. Market Revenue and Forecast, By Application (2016-2030)
11.1.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Technology (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Application (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, By Technology (2016-2030)
11.2.3. Market Revenue and Forecast, By Application (2016-2030)
11.2.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Technology (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Application (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Technology (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Application (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Technology (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Application (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, By Technology (2016-2030)
11.3.3. Market Revenue and Forecast, By Application (2016-2030)
11.3.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Technology (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Application (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Technology (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Application (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Technology (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Application (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, By Technology (2016-2030)
11.4.3. Market Revenue and Forecast, By Application (2016-2030)
11.4.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Technology (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Application (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Technology (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Application (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Technology (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Application (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Technology (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Application (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-Use (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Technology (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Application (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-Use (2016-2030)
Chapter 12. Company Profiles
12.1. BD
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. bioMérieux SA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Abbott
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Quidel Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. OraSure Technologies, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hologic, Inc. (Gen Probe)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Danaher
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. QIAGEN
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. F. Hoffmann-La Roche, Ltd.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Siemens Healthineers AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Bio-Rad Laboratories, Inc.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms